Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. November 2022 16:05 ET | Quelle: Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

EXTON, Pa. and DURHAM, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its consolidated financial and...
28. September 2022 16:09 ET | Quelle: Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals Acquires Aceragen

Acquisition includes late-stage rare disease portfolio with anticipated 2023 clinical milestones and first potential product approval as early as late 2024 Conference call and webcast today at 5:00...
24. Oktober 2017 14:29 ET | Quelle: Defense Threat Reduction Agency

Seeking Innovators to Defend Against Chemical and Biological Weapons

Fort Belvoir, Virginia, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Collaboration between government, academia and industry is key to defending our warfighters and nation from the evolving threat of weapons...